BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

239 related articles for article (PubMed ID: 10933691)

  • 1. E2F proteins are posttranslationally modified concomitantly with a reduction in nuclear binding activity in cells infected with herpes simplex virus 1.
    Advani SJ; Weichselbaum RR; Roizman B
    J Virol; 2000 Sep; 74(17):7842-50. PubMed ID: 10933691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases.
    Wang H; Shao N; Ding QM; Cui J; Reddy ES; Rao VN
    Oncogene; 1997 Jul; 15(2):143-57. PubMed ID: 9244350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Deregulated E2F transcriptional activity in autonomously growing melanoma cells.
    Halaban R; Cheng E; Smicun Y; Germino J
    J Exp Med; 2000 Mar; 191(6):1005-16. PubMed ID: 10727462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The E2F-family proteins induce distinct cell cycle regulatory factors in p16-arrested, U343 astrocytoma cells.
    Dirks PB; Rutka JT; Hubbard SL; Mondal S; Hamel PA
    Oncogene; 1998 Aug; 17(7):867-76. PubMed ID: 9780003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of a cAMP pathway and induction of melanogenesis correlate with association of p16(INK4) and p27(KIP1) to CDKs, loss of E2F-binding activity, and premature senescence of human melanocytes.
    Haddad MM; Xu W; Schwahn DJ; Liao F; Medrano EE
    Exp Cell Res; 1999 Dec; 253(2):561-72. PubMed ID: 10585280
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Induction of S-phase entry by E2F transcription factors depends on their nuclear localization.
    Müller H; Moroni MC; Vigo E; Petersen BO; Bartek J; Helin K
    Mol Cell Biol; 1997 Sep; 17(9):5508-20. PubMed ID: 9271426
    [TBL] [Abstract][Full Text] [Related]  

  • 7. E2F-1 but not E2F-4 can overcome p16-induced G1 cell-cycle arrest.
    Mann DJ; Jones NC
    Curr Biol; 1996 Apr; 6(4):474-83. PubMed ID: 8723352
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differential effects of cdk2 and cdk3 on the control of pRb and E2F function during G1 exit.
    Hofmann F; Livingston DM
    Genes Dev; 1996 Apr; 10(7):851-61. PubMed ID: 8846921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Regulation of E2F transcription by cyclin E-Cdk2 kinase mediated through p300/CBP co-activators.
    Morris L; Allen KE; La Thangue NB
    Nat Cell Biol; 2000 Apr; 2(4):232-9. PubMed ID: 10783242
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cdk2-dependent and -independent pathways in E2F-mediated S phase induction.
    Arata Y; Fujita M; Ohtani K; Kijima S; Kato JY
    J Biol Chem; 2000 Mar; 275(9):6337-45. PubMed ID: 10692433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulation of dihydrofolate reductase gene expression and E2F components in human diploid fibroblasts during growth and senescence.
    Good L; Dimri GP; Campisi J; Chen KY
    J Cell Physiol; 1996 Sep; 168(3):580-8. PubMed ID: 8816912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcellular compartmentalization of E2F family members is required for maintenance of the postmitotic state in terminally differentiated muscle.
    Gill RM; Hamel PA
    J Cell Biol; 2000 Mar; 148(6):1187-201. PubMed ID: 10725332
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cyclin A/CDK2 binds directly to E2F-1 and inhibits the DNA-binding activity of E2F-1/DP-1 by phosphorylation.
    Xu M; Sheppard KA; Peng CY; Yee AS; Piwnica-Worms H
    Mol Cell Biol; 1994 Dec; 14(12):8420-31. PubMed ID: 7969176
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphorylation of E2F-1 by cyclin A-cdk2.
    Kitagawa M; Higashi H; Suzuki-Takahashi I; Segawa K; Hanks SK; Taya Y; Nishimura S; Okuyama A
    Oncogene; 1995 Jan; 10(2):229-36. PubMed ID: 7838523
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association with E2F-1 governs intracellular trafficking and polyubiquitination of DP-1.
    Magae J; Illenye S; Chang YC; Mitsui Y; Heintz NH
    Oncogene; 1999 Jan; 18(3):593-605. PubMed ID: 9989809
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Collaborative role of E2F transcriptional activity and G1 cyclindependent kinase activity in the induction of S phase.
    Leone G; DeGregori J; Jakoi L; Cook JG; Nevins JR
    Proc Natl Acad Sci U S A; 1999 Jun; 96(12):6626-31. PubMed ID: 10359762
    [TBL] [Abstract][Full Text] [Related]  

  • 17. E2F4-RB and E2F4-p107 complexes suppress gene expression by transforming growth factor beta through E2F binding sites.
    Li JM; Hu PP; Shen X; Yu Y; Wang XF
    Proc Natl Acad Sci U S A; 1997 May; 94(10):4948-53. PubMed ID: 9144170
    [TBL] [Abstract][Full Text] [Related]  

  • 18. E2F as a regulator of keratinocyte proliferation: implications for skin tumor development.
    Jones SJ; Dicker AJ; Dahler AL; Saunders NA
    J Invest Dermatol; 1997 Aug; 109(2):187-93. PubMed ID: 9242506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Roles of E2F1 in mesangial cell proliferation in vitro.
    Inoshita S; Terada Y; Nakashima O; Kuwahara M; Sasaki S; Marumo F
    Kidney Int; 1999 Dec; 56(6):2085-95. PubMed ID: 10594784
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of E2F complexes during G0 to S phase transition in human primary B-lymphocytes.
    van der Sman J; Thomas NS; Lam EW
    J Biol Chem; 1999 Apr; 274(17):12009-16. PubMed ID: 10207023
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.